Pre-made Mibavademab biosimilar (Whole mAb, anti-LEPR therapeutic antibody, Anti-CD295/LEPRD/OB-R/OBR Antibody) - benchmark reference antibody

Cat No.: GMP-Bios-ab-343

Pre-made Mibavademab biosimilar (Whole mAb, anti-LEPR therapeutic antibody, Anti-CD295/LEPRD/OB-R/OBR Antibody) - benchmark reference antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-343-1mg 1mg 3090 Inquiry Inquiry

Size： 1mg | 10mg | 100mg

For more than 100mg, click here for inquiry. >>


Description

Products Name (INN Index) Pre-Made Mibavademab biosimilar, Whole mAb, Anti-LEPR Antibody: Anti-CD295/OB-R/OBR therapeutic antibody
INN Name Mibavademab
TargetLEPR
FormatWhole mAb
Derivation
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-II
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2020
Year Recommendedna
CompaniesRegeneron Pharmaceuticals
Conditions Approvedna
Conditions ActiveLipodystrophy
Conditions Discontinuedna
Development Techna